Conclusion: Despite the prevalence of gastrointestinal symptoms, semaglutide remains an efficacious option for managing diabetes and obesity. The detailed characterization of adverse events underscores the importance of monitoring and managing these effects in clinical practice, excluding the hypothesis of carcinogenesis.
PubMed 38673931 ↗GLP-1 Receptor Agonists
People mainly take GLP-1 Receptor Agonists for digestion, weight loss. Based on 3 first-hand reports and 486 meta-analyses & systematic reviews in the medical literature. Ranked #1991 of 3,539 overall.
Of reports that state an outcome, 50% are positive.
What GLP-1 Receptor Agonists does, according to users
Of the people who reported each effect, the share who said it got better.
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found.
Conclusion: Treatment with GLP-1 receptor agonists has beneficial effects on cardiovascular, mortality, and kidney outcomes in patients with type 2 diabetes.
PubMed 31422062 ↗Conclusion: GLP-1 RAs demonstrated significant weight, BMI, and waist circumference reduction benefits in this meta-analysis.
PubMed 39841962 ↗Conclusion: GLP-1RA have moderate benefits on MACE, and also reduce hospitalization for heart failure and all-cause mortality; they also have robust benefits on reducing the incidence of macroalbuminuria.
PubMed 34526024 ↗Dosage people report
As stated by users — not a recommendation. Follow the label or your doctor.
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“GLP meds have been a game changer for me. Started at 196-156lbs.”
“GLP-1's reduce inflammation and can reverse IBS for many. If anything I'd expect the opposite and it decreases colon cancer risks.”
Other options for digestion
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 3, 2026. How we rate